TapewireFind a company

person · Reporting owner

Peters Jeffrey Stuart

Disclosed activity across 1 company

Tapewire entity
21328
SEC CIK
0001706903

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
MACROGENICS INCMGNX · Entity 6104Senior VP, GC, and SecretaryAugust 19, 2026August 20, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

MACROGENICS INC

Report date August 19, 2026 · Filed August 20, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2026-08-19 transaction · row 1
1 source row

Row 1 · 2026-08-19 · Sale · Disposed 31,105 · Balance 0

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2026.

F2: This transaction was executed in multiple trades at prices ranging from $4.12 to $4.24. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2026.

F2: This transaction was executed in multiple trades at prices ranging from $4.12 to $4.24. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 19, 2026 Filed Aug 20, 2026 22:19 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 31,105 $4.15 $129,085.75
Disclosure

SEC source: 0001706903-26-000006 · wk-form4_1787264339.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $4.12 to $4.24. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 15, 2026 Filed Feb 17, 2026 23:25 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionRestricted Stock Unit · Derivative 13,332 $0.00 $0.00
Disclosure

SEC source: 0001706903-26-000004 · wk-form4_1771370708.xml · derivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,332 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023, the reporting person was granted 40,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023, the reporting person was granted 40,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023, the reporting person was granted 40,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 15, 2026 Filed Feb 17, 2026 23:25 UTC MACROGENICS INC MGNX · Entity 6104 Tax withholdingCommon Stock 5,147 $1.71 $8,801.37
Disclosure

SEC source: 0001706903-26-000004 · wk-form4_1771370708.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,105

Read SEC document
February 15, 2026 Filed Feb 17, 2026 23:25 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 13,332 Not disclosed Not disclosed
Disclosure

SEC source: 0001706903-26-000004 · wk-form4_1771370708.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,252

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023, the reporting person was granted 40,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 23:25 UTC MACROGENICS INC MGNX · Entity 6104 GrantRestricted Stock Unit · Derivative 25,000 $0.00 $0.00
Disclosure

SEC source: 0001706903-26-000004 · wk-form4_1771370708.xml · derivative · entry 5

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 23:25 UTC MACROGENICS INC MGNX · Entity 6104 GrantEmployee Stock Option (right to buy) · Derivative 150,000 $0.00 Strike: $1.71 $0.00
Disclosure

SEC source: 0001706903-26-000004 · wk-form4_1771370708.xml · derivative · entry 4

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2036-02-12

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

Read SEC document
February 08, 2026 Filed Feb 10, 2026 23:15 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionRestricted Stock Unit · Derivative 8,999 $0.00 $0.00
Disclosure

SEC source: 0001706903-26-000002 · wk-form4_1770765298.xml · derivative · entry 6

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 8,999 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into the Company's stock on a one-for-one basis.

F3 · derivative.exercise_date: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

Read SEC document
February 08, 2026 Filed Feb 10, 2026 23:15 UTC MACROGENICS INC MGNX · Entity 6104 Tax withholdingCommon Stock 3,474 $1.81 $6,287.94
Disclosure

SEC source: 0001706903-26-000002 · wk-form4_1770765298.xml · nonDerivative · entry 4

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,920

Read SEC document
February 08, 2026 Filed Feb 10, 2026 23:15 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 8,999 Not disclosed Not disclosed
Disclosure

SEC source: 0001706903-26-000002 · wk-form4_1770765298.xml · nonDerivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,394

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 07, 2026 Filed Feb 10, 2026 23:15 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionRestricted Stock Unit · Derivative 6,001 $0.00 $0.00
Disclosure

SEC source: 0001706903-26-000002 · wk-form4_1770765298.xml · derivative · entry 5

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,999

Underlying: Common Stock · 6,001 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into the Company's stock on a one-for-one basis.

F2 · derivative.exercise_date: On February 7, 2025, the reporting person was granted 18,000 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date

F2 · derivative.expiration_date: On February 7, 2025, the reporting person was granted 18,000 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date

Read SEC document
February 07, 2026 Filed Feb 10, 2026 23:15 UTC MACROGENICS INC MGNX · Entity 6104 Tax withholdingCommon Stock 2,317 $1.81 $4,193.77
Disclosure

SEC source: 0001706903-26-000002 · wk-form4_1770765298.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,395

Read SEC document
February 07, 2026 Filed Feb 10, 2026 23:15 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 6,001 Not disclosed Not disclosed
Disclosure

SEC source: 0001706903-26-000002 · wk-form4_1770765298.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP, GC, and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,712

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 20:12 UTC MACROGENICS INC MGNX · Entity 6104 GrantEmployee Stock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.58 $0.00
Disclosure

SEC source: 0001706903-25-000003 · wk-form4_1755634329.xml · derivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-08-15

F1 · derivative.exercise_date: 25% of the options will vest and become exercisable one year after the grant date and the remaining 75% will vest in 12 substantially equal quarterly installments thereafter.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 21:25 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionRestricted Stock Unit · Derivative 13,332 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000033 · wk-form4_1740000341.xml · derivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,332

Underlying: Common Stock · 13,332 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023, the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023, the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023, the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 15, 2025 Filed Feb 19, 2025 21:25 UTC MACROGENICS INC MGNX · Entity 6104 Tax withholdingCommon Stock 5,147 $2.56 $13,176.32
Disclosure

SEC source: 0001125345-25-000033 · wk-form4_1740000341.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,711

Read SEC document
February 15, 2025 Filed Feb 19, 2025 21:25 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 13,332 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000033 · wk-form4_1740000341.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,858

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023, the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 08, 2025 Filed Feb 12, 2025 01:19 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionRestricted Stock Unit · Derivative 9,001 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000012 · wk-form4_1739323154.xml · derivative · entry 5

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,999

Underlying: Common Stock · 9,001 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 08, 2025 Filed Feb 12, 2025 01:19 UTC MACROGENICS INC MGNX · Entity 6104 Tax withholdingCommon Stock 3,475 $2.60 $9,035.00
Disclosure

SEC source: 0001125345-25-000012 · wk-form4_1739323154.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,526

Read SEC document
February 08, 2025 Filed Feb 12, 2025 01:19 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 9,001 Not disclosed Not disclosed
Disclosure

SEC source: 0001125345-25-000012 · wk-form4_1739323154.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:19 UTC MACROGENICS INC MGNX · Entity 6104 GrantRestricted Stock Unit · Derivative 18,000 $0.00 $0.00
Disclosure

SEC source: 0001125345-25-000012 · wk-form4_1739323154.xml · derivative · entry 4

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Read SEC document
February 07, 2025 Filed Feb 12, 2025 01:19 UTC MACROGENICS INC MGNX · Entity 6104 GrantEmployee Stock Option (right to buy) · Derivative 105,000 $0.00 Strike: $2.60 $0.00
Disclosure

SEC source: 0001125345-25-000012 · wk-form4_1739323154.xml · derivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2035-02-07

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:07 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionEmployee stock option (right to buy) · Derivative 42,500 $4.82 Strike: $4.82 $204,850.00
Disclosure

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · derivative · entry 7

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,500

Underlying: Common Stock · 42,500 shares

Expires 2033-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

F6 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the 2/15/2023 date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:07 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 3,165 $18.22 $57,666.30
Disclosure

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 6

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $18.00 to $18.84. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:07 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 5,351 $17.74 $94,926.74
Disclosure

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 5

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,165

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $17.05 to $17.99. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:07 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 232 $16.38 $3,800.16
Disclosure

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 4

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,516

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $16.01 to $16.58. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:07 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 147 $15.51 $2,279.97
Disclosure

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,748

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.07 to $15.94. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:07 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 42,500 $15.07 $640,475.00
Disclosure

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,895

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:07 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 42,500 $4.82 $204,850.00
Disclosure

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,395

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2024 Filed Mar 8, 2024 21:14 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionEmployee stock option (right to buy) · Derivative 8,750 $10.15 Strike: $10.15 $88,812.50
Disclosure

SEC source: 0001125345-24-000063 · wk-form4_1709932476.xml · derivative · entry 5

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,375

Underlying: Common Stock · 8,750 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
March 06, 2024 Filed Mar 8, 2024 21:14 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionEmployee stock option (right to buy) · Derivative 10,875 $11.50 Strike: $11.50 $125,062.50
Disclosure

SEC source: 0001125345-24-000063 · wk-form4_1709932476.xml · derivative · entry 4

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,875 shares

Expires 2030-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Read SEC document
March 06, 2024 Filed Mar 8, 2024 21:14 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 19,625 $21.50 $421,937.50
Disclosure

SEC source: 0001125345-24-000063 · wk-form4_1709932476.xml · nonDerivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,895

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

Read SEC document
March 06, 2024 Filed Mar 8, 2024 21:14 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 8,750 $10.15 $88,812.50
Disclosure

SEC source: 0001125345-24-000063 · wk-form4_1709932476.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2024 Filed Mar 8, 2024 21:14 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 10,875 $11.50 $125,062.50
Disclosure

SEC source: 0001125345-24-000063 · wk-form4_1709932476.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,770

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 21:20 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 16,124 $17.22 $277,655.28
Disclosure

SEC source: 0001125345-24-000049 · wk-form4_1709155207.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,895

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $16.57 to $18.37. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 22, 2024 Filed Feb 26, 2024 21:27 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionRestricted Stock Unit · Derivative 26,250 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000047 · wk-form4_1708982859.xml · derivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 22, 2024 Filed Feb 26, 2024 21:27 UTC MACROGENICS INC MGNX · Entity 6104 Tax withholdingCommon Stock 10,126 $17.11 $173,255.86
Disclosure

SEC source: 0001125345-24-000047 · wk-form4_1708982859.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,019

Read SEC document
February 22, 2024 Filed Feb 26, 2024 21:27 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 26,250 $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000047 · wk-form4_1708982859.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 23:05 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionRestricted Stock Unit · Derivative 13,336 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000041 · wk-form4_1708470299.xml · derivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,664

Underlying: Common Stock · 13,336 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 23:05 UTC MACROGENICS INC MGNX · Entity 6104 Tax withholdingCommon Stock 4,441 $17.40 $77,273.40
Disclosure

SEC source: 0001125345-24-000041 · wk-form4_1708470299.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,895

Read SEC document
February 15, 2024 Filed Feb 20, 2024 23:05 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 13,336 $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000041 · wk-form4_1708470299.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,336

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document
February 08, 2024 Filed Feb 12, 2024 22:32 UTC MACROGENICS INC MGNX · Entity 6104 GrantRestricted Stock Unit · Derivative 27,000 $0.00 $0.00
Disclosure

SEC source: 0001125345-24-000020 · wk-form4_1707777115.xml · derivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Common Stock · 27,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Read SEC document
February 08, 2024 Filed Feb 12, 2024 22:32 UTC MACROGENICS INC MGNX · Entity 6104 GrantEmployee Stock Option (right to buy) · Derivative 71,000 $0.00 Strike: $18.30 $0.00
Disclosure

SEC source: 0001125345-24-000020 · wk-form4_1707777115.xml · derivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,000

Underlying: Common Stock · 71,000 shares

Expires 2034-02-08

F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 21:17 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionEmployee stock option (right to buy) · Derivative 21,875 $0.00 Strike: $10.15 $0.00
Disclosure

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · derivative · entry 6

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,125

Underlying: Common Stock · 21,875 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 21:17 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionEmployee stock option (right to buy) · Derivative 54,376 $0.00 Strike: $11.50 $0.00
Disclosure

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · derivative · entry 5

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,875

Underlying: Common Stock · 54,376 shares

Expires 2030-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 21:17 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 21,875 $16.50 $360,937.50
Disclosure

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · nonDerivative · entry 4

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 21:17 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 54,376 $16.50 $897,204.00
Disclosure

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · nonDerivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,875

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 21:17 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 21,875 $10.15 $222,031.25
Disclosure

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,251

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 21:17 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionCommon Stock 54,376 $11.50 $625,324.00
Disclosure

SEC source: 0001125345-24-000007 · wk-form4_1707340620.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 20:22 UTC MACROGENICS INC MGNX · Entity 6104 SaleCommon Stock 5,372 $6.03 $32,393.16
Disclosure

SEC source: 0001125345-23-000054 · wf-form4_167882533470011.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $5.80 to $6.18. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 22, 2023 Filed Feb 24, 2023 21:35 UTC MACROGENICS INC MGNX · Entity 6104 Exercise / conversionRestricted Stock Unit · Derivative 8,750 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001125345-23-000041 · wf-form4_167727448264875.xml · derivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.